MeSH Browser

MeSH Supplementary: MSK-NY-II protocol, modified
Unique ID: C100716
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C100716
Entry Term(s): AL841 protocol; modified MSK-NY-II protocol
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin; Methotrexate; Prednisolone; Vincristine
Frequency: 2
Note: a modified Memorial Sloan-Kettering-New York II protocol consisting of the above compounds
Source: Med Pediatr Oncol 1996 Sep;27(3):139-44
Date of Entry: 1996/09/04
Revision Date: 2001/08/31

MSK-NY-II protocol, modified MeSH Supplementary Concept Data 2024